Data on drug-related infectious diseases are collected at the national level through the National Retrovirology Laboratory and complemented by the information obtained through the multi-sector national network RELIS (the national monitoring system on drugs and drug addictions, based on self-reports) and specific studies. Luxembourg experienced a human immunodeficiency virus (HIV) outbreak among people who inject drugs (PWID) with a peak of 19 reported cases in 2016. In 2017, there were nine newly diagnosed cases of HIV infection associated with injecting drug use. The outbreak has been linked to, among other factors, an increase in cocaine injecting among marginalised groups. Responses to the outbreak included scaling up prevention and harm reduction services, testing and linkage to HIV treatment.
|Data from 2017.|
In 2017, diagnostic testing of 66 PWID from drug treatment centres, needle and syringes programmes, sexually transmitted infection clinics and prisons showed that around 1 in 10 PWID were HIV positive and three quarters were positive for hepatitis C virus (HCV) antibodies.